These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals. Sheiner LB J Pharmacokinet Biopharm; 1986 Oct; 14(5):539-55. PubMed ID: 3806375 [TBL] [Abstract][Full Text] [Related]
4. An analysis program MULTI(ELS) based on extended nonlinear least squares method for microcomputers. Yamaoka K; Tanaka H; Okumura K; Yasuhara M; Hori R J Pharmacobiodyn; 1986 Feb; 9(2):161-73. PubMed ID: 3754893 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares. Sheiner LB; Beal SL J Pharmacokinet Biopharm; 1985 Apr; 13(2):185-201. PubMed ID: 4057057 [TBL] [Abstract][Full Text] [Related]
6. Extended least squares nonlinear regression: a possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic data. Peck CC; Beal SL; Sheiner LB; Nichols AI J Pharmacokinet Biopharm; 1984 Oct; 12(5):545-58. PubMed ID: 6520748 [TBL] [Abstract][Full Text] [Related]
7. Analysis of pharmacokinetic data using parametric models. II. Point estimates of an individual's parameters. Sheiner LB J Pharmacokinet Biopharm; 1985 Oct; 13(5):515-40. PubMed ID: 3834066 [TBL] [Abstract][Full Text] [Related]
8. Analytical approximations of sensitivities of steady state predictions to errors in parameter estimation. Gonda I J Pharmacokinet Biopharm; 1982 Oct; 10(5):559-74. PubMed ID: 7166739 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data. Sheiner LB; Beal SL J Pharmacokinet Biopharm; 1980 Dec; 8(6):553-71. PubMed ID: 7229908 [TBL] [Abstract][Full Text] [Related]
10. An evaluation of extended vs weighted least squares for parameter estimation in physiological modeling. Spilker ME; Vicini P J Biomed Inform; 2001 Oct; 34(5):348-64. PubMed ID: 12123152 [TBL] [Abstract][Full Text] [Related]
11. The effects of active metabolites on parameter estimation in linear mixed effect models of concentration-QT analyses. Bonate PL J Pharmacokinet Pharmacodyn; 2013 Feb; 40(1):101-15. PubMed ID: 23288469 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of objective functions for estimation of kinetic parameters. Muzic RF; Christian BT Med Phys; 2006 Feb; 33(2):342-53. PubMed ID: 16532939 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of nonlinear regression with extended least squares: simulation study. Thomson AH; Kelman AW; Whiting B J Pharm Sci; 1985 Dec; 74(12):1327-30. PubMed ID: 4087201 [TBL] [Abstract][Full Text] [Related]
14. An iterative curve stripping technique for pharmacokinetic parameter estimation. Dunne A J Pharm Pharmacol; 1986 Feb; 38(2):97-101. PubMed ID: 2870170 [TBL] [Abstract][Full Text] [Related]
15. Extended least squares (ELS) for pharmacokinetic models. Metzler CM J Pharm Sci; 1987 Jul; 76(7):565-71. PubMed ID: 3668820 [TBL] [Abstract][Full Text] [Related]
16. Effect of heteroscedasticity between treatment groups on mixed-effects models for repeated measures. Gosho M; Maruo K Pharm Stat; 2018 Sep; 17(5):578-592. PubMed ID: 29978944 [TBL] [Abstract][Full Text] [Related]